UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 4200

Change

-44.75 (-1.05)%

Market Cap

N/A

Volume

53.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-0.13 (-0.05%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

-20.50 (-0.11%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+2.75 (+1.42%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.22 (-1.20%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.22 (-1.55%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

+1.37 (+1.27%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.37 (-1.21%)

USD 260.39B
0QZO:LSE 0QZO

-4.20 (-4.09%)

USD 258.54B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.29% 94% A 89% A-
Dividend Return 0.01% 22% F 19% F
Total Return 14.30% 94% A 89% A-
Trailing 12 Months  
Capital Gain 14.11% 87% B+ 79% B-
Dividend Return 0.04% 29% F 26% F
Total Return 14.16% 86% B+ 78% C+
Trailing 5 Years  
Capital Gain 42.68% 45% F 56% F
Dividend Return 0.20% 28% F 38% F
Total Return 42.87% 41% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 8.59% 56% F 62% D
Dividend Return 8.60% 55% F 61% D-
Total Return 0.00% 19% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 12.21% 59% D- 75% C
Risk Adjusted Return 70.41% 68% D+ 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.